Autori: Beebe Jean S
Naslov | Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article) |
Autori | Robinson Michael F Damjanov Nemanja S Stamenkovic Bojana N ![]() ![]() |
Info | ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631 |
Projekat | Pfizer, Inc.Pfizer |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article) |
Autori | Robinson Michael F Damjanov Nemanja S Stamenkovic Bojana N ![]() ![]() |
Info | ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631 |
Projekat | Pfizer, Inc.Pfizer |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|